Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzydamine spray versus lozenges for acute sore throat
2019-003257-29Phase 4Completed
- Sponsor
- Angelini Pharma
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of benzydamine in acute pharyngitis and tonsillopharyngitis (2 arms), sponsored by Angelini Pharma. Primary endpoint: Responders at 2 minutes after first dose. Started Dec 2019; status: completed.
02
Drugs
benzydamine
03
Conditions
acute pharyngitistonsillopharyngitis
Beyond the preview
Go deeper on 2019-003257-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003257-29.